EW
insider transactionsEdwards Lifesciences Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-120.0K
0 buy · 120.0K sell
Net value · 90d
-$9.7M
$0 in · $9.7M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
18
0 buy · 120.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
CEO · 10b5-1
$46.0K
523 sh · $87.92
Own -4%
-
Sell·S
SVP, Corporate Controller
$48.9K
568 sh · $86.08
Own -4%
-
Sell·S
CVP,Strategy/Corp Development
$2.0M
23.1K sh · $86.42
Own -19%
-
Sell·S
CVP, TMTT & Surgical
$126.9K
1.5K sh · $84.60
Own -3%
-
Exercise·M
CVP, TAVR · 10b5-1
$0
620 sh
Own +11%
-
Sell·S
CVP, TAVR · 10b5-1
$50.3K
620 sh · $81.14
Own -2%
-
Exercise·M
CVP, TAVR · 10b5-1
$45.1K
620 sh · $72.68
Own +2%
-
Sell·S
CVP,Strategy/Corp Development
$654.6K
8.0K sh · $81.82
Own -21%
-
Sell·S
CVP,Strategy/Corp Development
$818.1K
10.0K sh · $82.07
Own -30%
-
Sell·S
CEO · 10b5-1
$2.8M
35.5K sh · $77.92
Own -75%
-
Sell·S
CEO · 10b5-1
$66.3K
845 sh · $78.40
Own -2%
-
Other·G
CEO · 10b5-1
$0
26.6K sh
Own -21%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer
$0
19.8K sh
Own New
-
Other·F
Scott B. Ullem KEY
CVP, Chief Financial Officer
$879.9K
11.0K sh · $79.96
Own -19%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer
$0
19.8K sh
Own +52%
-
Sell·S
CVP, JAPAC
$47.3K
593 sh · $79.73
Own -3%
-
Other·G
CEO
$0
5.5K sh
Own -5%
-
Other·F
CVP, TAVR
$28.9K
362 sh · $79.96
Own -1%
-
Exercise·M
CEO · 10b5-1
$0
47.2K sh
Own New
-
Other·F
CEO · 10b5-1
$2.1M
26.2K sh · $79.96
Own -17%
-
Exercise·M
CEO · 10b5-1
$0
47.2K sh
Own +43%
-
Exercise·M
CVP, TMTT & Surgical
$0
13.6K sh
Own New
-
Other·F
CVP, TMTT & Surgical
$602.7K
7.5K sh · $79.96
Own -14%
-
Exercise·M
CVP, TMTT & Surgical
$0
13.6K sh
Own +34%
-
Exercise·M
CVP,Strategy/Corp Development
$0
13.5K sh
Own New
-
Other·F
CVP,Strategy/Corp Development
$597.2K
7.5K sh · $79.96
Own -19%
-
Exercise·M
CVP,Strategy/Corp Development
$0
13.5K sh
Own +50%
-
Grant·A
Director
$0
5.1K sh
Own +6%
-
Grant·A
Director
$0
3.3K sh
Own +92%
-
Grant·A
Director
$0
1.1K sh
Own +13%
-
Grant·A
Director
$0
3.3K sh
Own +69%
-
Grant·A
Director
$0
3.3K sh
Own +23%
-
Grant·A
Director
$0
3.3K sh
Own +11%
-
Grant·A
Director
$0
1.1K sh
Own +33%
-
Grant·A
Director
$0
3.3K sh
Own New
-
Grant·A
Director
$0
3.3K sh
Own +56%
-
Other·F
Scott B. Ullem KEY
CVP, Chief Financial Officer
$137.5K
1.7K sh · $82.76
Own -4%
-
Other·F
CVP, TAVR
$37.2K
450 sh · $82.76
Own -1%
-
Grant·A
Director
$0
3.3K sh
Own +49%
-
Other·F
SVP, Corporate Controller
$23.9K
289 sh · $82.76
Own -2%
-
Other·F
CVP, TMTT & Surgical
$94.4K
1.1K sh · $82.76
Own -3%
-
Other·F
CVP, EMEACLA
$7.0K
84 sh · $82.76
Own -0%
-
Other·F
CVP,Strategy/Corp Development
$85.9K
1.0K sh · $82.76
Own -4%
-
Other·F
CVP, JAPAC
$18.7K
226 sh · $82.76
Own -1%
-
Other·F
CEO
$446.7K
5.4K sh · $82.76
Own -5%
-
Other·G
CEO
$0
4.2K sh
Own -4%
-
Other·F
Scott B. Ullem KEY
CVP, Chief Financial Officer
$114.2K
1.4K sh · $83.20
Own -3%
-
Grant·A
CVP, TAVR
$0
7.8K sh
Own New
-
Grant·A
CVP, TAVR
$0
39.9K sh
Own New
-
Other·F
CVP, TAVR
$25.7K
309 sh · $83.20
Own -1%
-
Grant·A
CVP, TAVR
$0
7.8K sh
Own +23%
-
Grant·A
SVP, Corporate Controller
$0
6.7K sh
Own New
-
Grant·A
SVP, Corporate Controller
$0
3.0K sh
Own +23%
-
Grant·A
SVP, Corporate Controller
$0
4.0K sh
Own +43%
-
Grant·A
CVP, TMTT & Surgical
$0
9.7K sh
Own New
-
Grant·A
CVP, TMTT & Surgical
$0
49.1K sh
Own New
-
Other·F
CVP, TMTT & Surgical
$56.1K
674 sh · $83.20
Own -2%
-
Grant·A
CVP, TMTT & Surgical
$0
9.7K sh
Own +30%
-
Grant·A
CVP, EMEACLA
$0
6.7K sh
Own New
-
Grant·A
CVP, EMEACLA
$0
33.7K sh
Own New
-
Grant·A
CVP, EMEACLA
$0
6.7K sh
Own +47%
-
Grant·A
CVP,Strategy/Corp Development
$0
7.8K sh
Own New
-
Grant·A
CVP,Strategy/Corp Development
$0
44.0K sh
Own New
-
Other·F
CVP,Strategy/Corp Development
$69.1K
831 sh · $83.20
Own -3%
-
Grant·A
CVP,Strategy/Corp Development
$0
7.8K sh
Own +38%
-
Grant·A
CVP, JAPAC
$0
5.2K sh
Own New
-
Grant·A
CVP, JAPAC
$0
26.4K sh
Own New
-
Other·F
CVP, JAPAC
$22.0K
264 sh · $83.20
Own -1%
-
Grant·A
CVP, JAPAC
$0
5.2K sh
Own +30%
-
Grant·A
CEO
$0
43.8K sh
Own New
-
Grant·A
CEO
$0
245.3K sh
Own New
-
Other·F
CEO
$345.5K
4.2K sh · $83.20
Own -3%
-
Grant·A
CEO
$0
43.8K sh
Own +55%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer
$0
13.0K sh
Own New
-
Other·F
Scott B. Ullem KEY
CVP, Chief Financial Officer
$922.9K
11.1K sh · $82.91
Own -21%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer
$770.3K
13.0K sh · $59.26
Own +33%
-
Other·G
CEO
$0
523 sh
Own -1%
-
Exercise·M
CVP, TAVR · 10b5-1
$0
1.0K sh
Own New
-
Sell·S
CVP, TAVR · 10b5-1
$85.6K
1.0K sh · $83.98
Own -3%
-
Exercise·M
CVP, TAVR · 10b5-1
$60.4K
1.0K sh · $59.26
Own +3%
-
Other·F
CVP, TAVR · 10b5-1
$21.2K
252 sh · $83.98
Own -1%
-
Other·F
CVP, TMTT & Surgical
$23.7K
282 sh · $83.98
Own -1%
-
Other·F
CVP,Strategy/Corp Development
$39.4K
469 sh · $83.98
Own -2%
-
Other·F
Scott B. Ullem KEY
CVP, Chief Financial Officer
$52.1K
620 sh · $83.98
Own -2%
-
Other·F
CEO
$43.2K
515 sh · $83.98
Own -1%
-
Exercise·M
CVP, TAVR · 10b5-1
$0
1.0K sh
Own New
-
Sell·S
CVP, TAVR · 10b5-1
$83.0K
1.0K sh · $82.99
Own -3%
-
Sell·S
CVP, TAVR · 10b5-1
$1.6K
19 sh · $83.99
Own -0%
-
Exercise·M
CVP, TAVR · 10b5-1
$60.4K
1.0K sh · $59.26
Own +3%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer · 10b5-1
$0
13.0K sh
Own New
-
Sell·S
Scott B. Ullem KEY
CVP, Chief Financial Officer · 10b5-1
$664.1K
8.3K sh · $79.79
Own -17%
-
Sell·S
Scott B. Ullem KEY
CVP, Chief Financial Officer · 10b5-1
$376.4K
4.7K sh · $80.50
Own -9%
-
Exercise·M
Scott B. Ullem KEY
CVP, Chief Financial Officer · 10b5-1
$770.3K
13.0K sh · $59.26
Own +33%
-
Exercise·M
CVP, TAVR · 10b5-1
$0
1.0K sh
Own +100%
-
Sell·S
CVP, TAVR · 10b5-1
$82.5K
1.0K sh · $80.98
Own -3%
-
Exercise·M
CVP, TAVR · 10b5-1
$60.4K
1.0K sh · $59.26
Own +3%
-
Exercise·M
CVP,Strategy/Corp Development · 10b5-1
$0
22.7K sh
Own New
-
Sell·S
CVP,Strategy/Corp Development · 10b5-1
$1.4M
18.0K sh · $80.05
Own -46%
-
Sell·S
CVP,Strategy/Corp Development · 10b5-1
$376.8K
4.7K sh · $80.59
Own -11%
-
Exercise·M
CVP,Strategy/Corp Development · 10b5-1
$1.3M
22.7K sh · $59.26
Own +107%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Bernard J Zovighian KEY 10b5-1 | Sell S | 523 | $46.0K |
| May 29, 2026 | Andrew M. Dahl | Sell S | 568 | $48.9K |
| May 27, 2026 | Donald E Bobo JR | Sell S | 23.1K | $2.0M |
| May 22, 2026 | Daveen Chopra | Sell S | 1.5K | $126.9K |
| May 18, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 620 | $0 |
| May 18, 2026 | Daniel J. Lippis 10b5-1 | Sell S | 620 | $50.3K |
| May 18, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 620 | $45.1K |
| May 15, 2026 | Donald E Bobo JR | Sell S | 8.0K | $654.6K |
| May 15, 2026 | Donald E Bobo JR | Sell S | 10.0K | $818.1K |
| May 12, 2026 | Bernard J Zovighian KEY 10b5-1 | Sell S | 35.5K | $2.8M |
| May 12, 2026 | Bernard J Zovighian KEY 10b5-1 | Sell S | 845 | $66.3K |
| May 12, 2026 | Bernard J Zovighian KEY 10b5-1 | Other G | 26.6K | $0 |
| May 11, 2026 | Scott B. Ullem KEY | Exercise M | 19.8K | $0 |
| May 11, 2026 | Scott B. Ullem KEY | Other F | 11.0K | $879.9K |
| May 11, 2026 | Scott B. Ullem KEY | Exercise M | 19.8K | $0 |
| May 11, 2026 | Wayne Markowitz | Sell S | 593 | $47.3K |
| May 11, 2026 | Bernard J Zovighian KEY | Other G | 5.5K | $0 |
| May 11, 2026 | Daniel J. Lippis | Other F | 362 | $28.9K |
| May 11, 2026 | Bernard J Zovighian KEY 10b5-1 | Exercise M | 47.2K | $0 |
| May 11, 2026 | Bernard J Zovighian KEY 10b5-1 | Other F | 26.2K | $2.1M |
| May 11, 2026 | Bernard J Zovighian KEY 10b5-1 | Exercise M | 47.2K | $0 |
| May 11, 2026 | Daveen Chopra | Exercise M | 13.6K | $0 |
| May 11, 2026 | Daveen Chopra | Other F | 7.5K | $602.7K |
| May 11, 2026 | Daveen Chopra | Exercise M | 13.6K | $0 |
| May 11, 2026 | Donald E Bobo JR | Exercise M | 13.5K | $0 |
| May 11, 2026 | Donald E Bobo JR | Other F | 7.5K | $597.2K |
| May 11, 2026 | Donald E Bobo JR | Exercise M | 13.5K | $0 |
| May 8, 2026 | Nicholas J Valeriani | Grant A | 5.1K | $0 |
| May 8, 2026 | Ramona Sequeira | Grant A | 3.3K | $0 |
| May 8, 2026 | Steven R Loranger | Grant A | 1.1K | $0 |
| May 8, 2026 | Steven R Loranger | Grant A | 3.3K | $0 |
| May 8, 2026 | Paul A Laviolette | Grant A | 3.3K | $0 |
| May 8, 2026 | Heisz Leslie Stone | Grant A | 3.3K | $0 |
| May 8, 2026 | Kieran Gallahue | Grant A | 1.1K | $0 |
| May 8, 2026 | Kieran Gallahue | Grant A | 3.3K | $0 |
| May 8, 2026 | David T Feinberg | Grant A | 3.3K | $0 |
| May 8, 2026 | Scott B. Ullem KEY | Other F | 1.7K | $137.5K |
| May 8, 2026 | Daniel J. Lippis | Other F | 450 | $37.2K |
| May 8, 2026 | Leslie C. Davis | Grant A | 3.3K | $0 |
| May 8, 2026 | Andrew M. Dahl | Other F | 289 | $23.9K |
| May 8, 2026 | Daveen Chopra | Other F | 1.1K | $94.4K |
| May 8, 2026 | Annette Bruls | Other F | 84 | $7.0K |
| May 8, 2026 | Donald E Bobo JR | Other F | 1.0K | $85.9K |
| May 8, 2026 | Wayne Markowitz | Other F | 226 | $18.7K |
| May 8, 2026 | Bernard J Zovighian KEY | Other F | 5.4K | $446.7K |
| May 8, 2026 | Bernard J Zovighian KEY | Other G | 4.2K | $0 |
| May 7, 2026 | Scott B. Ullem KEY | Other F | 1.4K | $114.2K |
| May 7, 2026 | Daniel J. Lippis | Grant A | 7.8K | $0 |
| May 7, 2026 | Daniel J. Lippis | Grant A | 39.9K | $0 |
| May 7, 2026 | Daniel J. Lippis | Other F | 309 | $25.7K |
| May 7, 2026 | Daniel J. Lippis | Grant A | 7.8K | $0 |
| May 7, 2026 | Andrew M. Dahl | Grant A | 6.7K | $0 |
| May 7, 2026 | Andrew M. Dahl | Grant A | 3.0K | $0 |
| May 7, 2026 | Andrew M. Dahl | Grant A | 4.0K | $0 |
| May 7, 2026 | Daveen Chopra | Grant A | 9.7K | $0 |
| May 7, 2026 | Daveen Chopra | Grant A | 49.1K | $0 |
| May 7, 2026 | Daveen Chopra | Other F | 674 | $56.1K |
| May 7, 2026 | Daveen Chopra | Grant A | 9.7K | $0 |
| May 7, 2026 | Annette Bruls | Grant A | 6.7K | $0 |
| May 7, 2026 | Annette Bruls | Grant A | 33.7K | $0 |
| May 7, 2026 | Annette Bruls | Grant A | 6.7K | $0 |
| May 7, 2026 | Donald E Bobo JR | Grant A | 7.8K | $0 |
| May 7, 2026 | Donald E Bobo JR | Grant A | 44.0K | $0 |
| May 7, 2026 | Donald E Bobo JR | Other F | 831 | $69.1K |
| May 7, 2026 | Donald E Bobo JR | Grant A | 7.8K | $0 |
| May 7, 2026 | Wayne Markowitz | Grant A | 5.2K | $0 |
| May 7, 2026 | Wayne Markowitz | Grant A | 26.4K | $0 |
| May 7, 2026 | Wayne Markowitz | Other F | 264 | $22.0K |
| May 7, 2026 | Wayne Markowitz | Grant A | 5.2K | $0 |
| May 7, 2026 | Bernard J Zovighian KEY | Grant A | 43.8K | $0 |
| May 7, 2026 | Bernard J Zovighian KEY | Grant A | 245.3K | $0 |
| May 7, 2026 | Bernard J Zovighian KEY | Other F | 4.2K | $345.5K |
| May 7, 2026 | Bernard J Zovighian KEY | Grant A | 43.8K | $0 |
| May 5, 2026 | Scott B. Ullem KEY | Exercise M | 13.0K | $0 |
| May 5, 2026 | Scott B. Ullem KEY | Other F | 11.1K | $922.9K |
| May 5, 2026 | Scott B. Ullem KEY | Exercise M | 13.0K | $770.3K |
| May 5, 2026 | Bernard J Zovighian KEY | Other G | 523 | $0 |
| May 4, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $0 |
| May 4, 2026 | Daniel J. Lippis 10b5-1 | Sell S | 1.0K | $85.6K |
| May 4, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $60.4K |
| May 3, 2026 | Daniel J. Lippis 10b5-1 | Other F | 252 | $21.2K |
| May 3, 2026 | Daveen Chopra | Other F | 282 | $23.7K |
| May 3, 2026 | Donald E Bobo JR | Other F | 469 | $39.4K |
| May 3, 2026 | Scott B. Ullem KEY | Other F | 620 | $52.1K |
| May 3, 2026 | Bernard J Zovighian KEY | Other F | 515 | $43.2K |
| May 1, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $0 |
| May 1, 2026 | Daniel J. Lippis 10b5-1 | Sell S | 1.0K | $83.0K |
| May 1, 2026 | Daniel J. Lippis 10b5-1 | Sell S | 19 | $1.6K |
| May 1, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $60.4K |
| Apr 9, 2026 | Scott B. Ullem KEY 10b5-1 | Exercise M | 13.0K | $0 |
| Apr 9, 2026 | Scott B. Ullem KEY 10b5-1 | Sell S | 8.3K | $664.1K |
| Apr 9, 2026 | Scott B. Ullem KEY 10b5-1 | Sell S | 4.7K | $376.4K |
| Apr 9, 2026 | Scott B. Ullem KEY 10b5-1 | Exercise M | 13.0K | $770.3K |
| Apr 6, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $0 |
| Apr 6, 2026 | Daniel J. Lippis 10b5-1 | Sell S | 1.0K | $82.5K |
| Apr 6, 2026 | Daniel J. Lippis 10b5-1 | Exercise M | 1.0K | $60.4K |
| Apr 2, 2026 | Donald E Bobo JR 10b5-1 | Exercise M | 22.7K | $0 |
| Apr 2, 2026 | Donald E Bobo JR 10b5-1 | Sell S | 18.0K | $1.4M |
| Apr 2, 2026 | Donald E Bobo JR 10b5-1 | Sell S | 4.7K | $376.8K |
| Apr 2, 2026 | Donald E Bobo JR 10b5-1 | Exercise M | 22.7K | $1.3M |
About EW insider trading
This page tracks insider transactions for Edwards Lifesciences Corp (EW) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.